HOME >> MEDICINE >> NEWS
Understanding cancer patients' needs, concerns, is key to improving clinical trial participation

(ORLANDO, Fla.) -- Advances in cancer treatment depend on carefully controlled trials of new therapies, yet only two to four percent of cancer patients nationwide take part in these pivotal studies. Understanding the decision to participate in a clinical trial -- from the patients point of view -- is a first step toward devising strategies to increase participation, according to researchers at UC Davis School of Medicine and Medical Center.

We really need to understand the patients perspective better, said Debora Paterniti, assistant professor of general medicine and author of a new study designed to fill that gap. The study was presented Sunday at the annual meeting of the American Society of Clinical Oncology in Orlando, Fla.

In the study, Paterniti closely observed cancer patients as they contemplated whether to participate in phase I and phase III clinical trials at UC Davis Cancer Center. Carried out over a three-month period, the observations focused not only on physician-patient and researcher-patient interactions, but also on physician-physician and patient-family interactions.

The observations turned up five broad categories of potential barriers to participation: lack of resources on the part of patients; health insurance restrictions; confusion about the difference between research and medical care; confusion about study procedures; and misunderstandings of the illness and its severity.

The observations also turned up three potential barriers to truly voluntary clinical trial participation by patients: desire on the part of a patient to please a family member or physician; a feeling by the patient that no other options exist; and perceptions by patients that they are required to be in a clinical trial.

In phase two of the study, Paterniti and her colleagues are now conducting in-depth interviews with patients. After all the data have been gathered, the researchers hope to use their findings to propose strateg
'"/>

Contact: Claudia Morain
cmmorain@ucdavis.edu
916-734-9023
University of California, Davis - Health System
19-May-2002


Page: 1 2 3

Related medicine news :

1. Understanding how vulnerabilities may keep women in abusive relationships
2. From town planning to intimate sex: Understanding the risks in our lives
3. Understanding how prostaglandin prevents gut injury during radiation therapy
4. Understanding epilepsy
5. The long view: Understanding why cancer strikes late
6. Understanding the autoimmune response in type 1 diabetes
7. Understanding nerve degeneration in spastic paraplegia
8. Understanding how lymph nodes respond to infection may redefine how immune system functions
9. Understanding Alzheimers disease: Animal research points to new direction for therapy
10. Understanding genetic cancer risk might not help smokers kick the habit
11. Understanding Why Antibiotics May Be Over-prescribed For Patients With Sore Throats

Post Your Comments:
(Date:5/24/2013)... Let’s face it: very few are luckily gifted ... majority of people to be uncomfortable with the color of ... addiction or simply genetics, yellowish or stained teeth suppresses confidence ... , Herald Square Dental is proud to announce the ... White Max. , Teeth become discolored for a number ...
(Date:5/24/2013)... Chino, CA (PRWEB) May 24, 2013 Area ... huge selection of new hot tubs to choose from at ... Super Sale . The sales event takes place at ... May 26, 2013. , Jacuzzi, the industry's leading hot ... sale traveling across the country. The event will feature popular ...
(Date:5/24/2013)... 24, 2013 The nation’s first trial ... Surgical Inc.’s da Vinci Surgical System concluded yesterday, Bernstein ... Washington State Court jury ruled in a 10-to-2 decision ... surgeon who performed a da Vinci prostatectomy on a ... family had alleged in their lawsuit that the da ...
(Date:5/24/2013)... of infantile myofibromatosis (IM)a disorder characterized by multiple tumors ... therapeutic targets, according to researchers from the Icahn School ... the American Journal of Human Genetics , may ... for which the only current treatment option is repeated ... inheritied disorder that develops in infancy or even in ...
(Date:5/24/2013)... 24, 2013 BestSatelliteProviders.com the online ... thousands of consumers compare the features and services ... site recently released the rankings of the best ... available for viewing on their website. , ... According to Adam Matthews, the spokesperson for BestSatelliteProviders.com, ...
Breaking Medicine News(10 mins):Health News:Herald Square Dental Introduces New In-office Whitening System: Venus White Max 2Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 2Health News:Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on Verdict in Nation’s First Trial Involving Alleged Da Vinci Complications 3Health News:Researchers identify first drug targets in childhood genetic tumor disorder 2Health News:Best Rural Internet Service Provider in 2013 by BestSatelliteProviders.com 2
(Date:5/24/2013)... 2013 Solta Medical, Inc. (NASDAQ: SLTM ... reported Dr. Edward W. Knowlton has ... effective immediately.  Dr. Knowlton is the founder of Thermage, the ... director since 1996. "On behalf of the entire ... would like to thank Ed for his tireless dedication to ...
(Date:5/24/2013)... 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ... the Deutsche Bank Health Care Conference to be held ... Adrian Adams , Chief Executive Officer ... the Company and its product pipeline at 12:00 p.m. ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will ...
(Date:5/24/2013)... GARDEN CITY, England and ... Heptares Therapeutics, the leading GPCR drug discovery and development company, is ... Usui as a Consultant to augment the Company,s business ... territories. Mr Usui has more than 15 years of ... industry including senior roles at Perlegen Sciences, Inc., Roche Pharma ( ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
Cached News: